APOLLO HOSPITALS ENTER. L vs ONYX BIOTEC LIMITED

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and ONYX BIOTEC LIMITED (ONYX) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, APOLLO HOSPITALS ENTER. L leads APOLLOHOSP vs ONYX on 7 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
13.77
13.42
P/B ratio
1.20
0.11%
Dividend yield
0.00%
₹135.04
EPS
₹2.73

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
-0.38%
18.00%
Return on capital
12.16%
15.00%
EBITDA margin
16.76%
7.94%
Net margin
7.99%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
20.72%
33.39%
Profit CAGR (3Y)

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹67 Cr
₹25,228 Cr
Revenue
₹62 Cr
₹2,003 Cr
Net profit
₹5 Cr
0.90
Debt / equity
0.27
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
ONYX BIOTEC LIMITED
  • ["Company has low interest coverage ratio.", "Company has a low return on equity of 6.49% over last 3 years."]
APOLLO HOSPITALS ENTER. L full analysis ONYX BIOTEC LIMITED full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.